BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• MC Services AG Hosts Press Lounge of German Equity Forum 2017

  MC Services AG, the international Public Relations and Investor Relations firm specializing in financial communications is again sponsoring the “Deutsches Eigenkapitalforum” (German Equity Forum), being held in Frankfurt am Main, November 27-29, 2017

  November 2, 2017

   · 

  2 min read
• Business

  IntelGenx to Report Third Quarter 2017 Financial Results on November 9, 2017 - Conference Call to Follow

  An accompanying conference call will be hosted by Dr. Horst G. Zerbe, President and Chief Executive Officer, and Mr. Andre Godin, Executive Vice-President and Chief Financial Officer, to discuss the results and provide a business update.

  November 2, 2017

   · 

  1 min read
• MTPConnect Opens Call For $5M Biomedtech Horizons Program, Supporting High-Potential Health Breakthroughs

  The BioMedTech Horizons program will provide $5M in 2017-18 to help Australia move more cutting-edge ideas and breakthrough discoveries towards proof-of-concept and commercialisation.

  November 2, 2017

   · 

  3 min read
• Topas Therapeutics Extends Its Series A to EUR 18 Million (USD 21 Million) With Boehringer Ingelheim Venture Fund

  BIVF will provide Topas with EUR 4 million (USD 5 million) to accelerate the Company’s preparation and execution of clinical trials for autoimmune programs derived from its platform.

  November 2, 2017

   · 

  3 min read
• Policy

  Moleculin Announces MD Anderson Has Filed an IND With the FDA on its Drug WP1066 for the Treatment of Brain Tumors

  Moleculin Biotech today announced that responses to FDA requests for additional information relating to the physician-sponsored IND application to study WP1066 as a potential treatment for brain tumors have been submitted.

  November 2, 2017

   · 

  3 min read
• Deals

  Citoxlab Acquires Xenometrics, an American CRO Specialized in Preclinical Assessment of New Drug Candidates

  This acquisition is the third one made by Citoxlab in North America further to the acquisition of the LAB Research Group and Accellab.

  November 2, 2017

   · 

  4 min read
• Biotech Bay

  BioCardia Announces Revised Effective Date of One-for-Twelve Reverse Stock Split

  Trading on a split-adjusted basis is planned to begin when the market opens on November 3, 2017 under the new trading symbol “BCDAD” and in 20 business days, the trading symbol will revert back to our existing symbol, “BCDA”.

  November 2, 2017

   · 

  2 min read
• Business

  Aeterna Zentaris to Announce Third Quarter 2017 Financial and Operating Results on November 8, 2017

  The Company will host a conference call to discuss these results on Thursday, November 9, 2017 at 8:30 a.m. Eastern Time.

  November 2, 2017

   · 

  1 min read
• Biotech Bay

  Innovative Rehab Technology Firm AlterG Gets a Lift From Business Capital

  Business Capital has delivered an $8MM financing package for AlterG., a company that manufactures and sells medical equipment for rehabilitation, athletic training, and exercise enablement.

  November 2, 2017

   · 

  2 min read
• Business

  Teva Reports Third Quarter 2017 Financial Results

  Revenues in the third quarter of 2017 were $5.6 billion, up 1% compared to the third quarter of 2016.

  November 2, 2017

   · 

  41 min read